NEWS
BioStock’s article series on autoimmune disease: Drug development for RA and MS
Therapies for autoimmune diseases are available but do not work for all patients, and when they do, side effects can be severe. There is a strong need for new therapies and therefore there is a [...]
A valuable and engaged support
We are grateful for the valuable and engaged support from our Umeå Biotech Incubator coach Anne-Charlotte Aronsson. After three years with us she is now moving on and we hope there will be time for [...]
Kallelse till årsstämma i Lipum AB
Aktieägarna i Lipum AB, org. nr. 556813-5999 (“Lipum”), kallas härmed till årsstämma fredagen den 28 juni 2019, kl. 09:00 på Tvistevägen 48C i Umeå. […]
Getting roasted by investors
As a Horizon 2020 beneficiary we are invited to the SME Instrument Phase 2 Welcome Day organized by the European Innovation Council (EIC) Pilot in Brussels, May 22-23. Besides business networking the agenda includes: “Get [...]
Welcome to Lipum, Pernilla!
Name: Pernilla Abrahamsson Education: PhD in medicine Age: 46 Family: Married, two teenagers Hobbies: We spend a lot of time in the cottage and the whole family goes cross-country skiing. It feels good [...]
Pernilla Abrahamsson joins as Chief Operating Officer
”Lipum is a very interesting company in an exciting development. Soon in the clinical phase and I am looking forward to all challenges ahead of us”, says Pernilla Abrahamsson. […]
Umeå life science company attends world congress –
“Our product has huge potential”
Umeå life science company Lipum will participate in one of the world's largest congresses for rheumatic diseases this June. “The elite of our industry gathers at this congress once a year and competition is incredibly [...]
Lipum attracts interest from life science leaders
Lipum is attending two significant events in Vienna next week. At the RESI Europe and the BIO-Europe Spring meetings we will meet with key decision makers from the pharma and venture capital segments. These events [...]
Lipum and Abzena sign integrated CMC agreement
Abzena, the global biologics gene to GMP partner research organization, announced it has signed an agreement to support an integrated CMC program with Lipum, a company developing treatments for chronic inflammatory diseases. Abzena will support [...]